Zobrazeno 1 - 10 of 50 pro vyhledávání: '"Shi Yang Zhu"'
2
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Metagenomics study on taxonomic and functional change of gut microbiota in patients with obesity with PCOS treated with exenatide combination with metformin or metformin alone
Autor: Jingwen Gan, Jie Chen, Rui-Lin Ma, Yan Deng, Xue-Song Ding, Shi-Yang Zhu, Ai-Jun Sun
Publikováno v: Gynecological Endocrinology, Vol 39, Iss 1 (2023)
Objective To investigate the effect of exenatide treatment on the composition of intestinal flora and metabolic pathways in patients with obesity with polycystic ovary syndrome.Methods Patients with obesity with polycystic ovary syndrome (PCOS) were
Externí odkaz: https://doaj.org/article/a2438abcfc014ba08e1f211729d985cc
Zobrazit plný text záznamu
4
Akademický článek
Action Mechanisms of Metformin Combined with Exenatide and Metformin Only in the Treatment of PCOS in Obese Patients
Autor: Jingwen Gan, Jie Chen, Rui-lin Ma, Yan Deng, Xue-song Ding, Shi-yang Zhu, Ai-jun Sun
Publikováno v: International Journal of Endocrinology, Vol 2023 (2023)
Background. Polycystic ovary syndrome (PCOS) is the most common endocrine disease in women of reproductive age, whose clinical characteristics are hyperandrogenism (HA), ovulatory dysfunction, and polycystic ovary, often accompanied by insulin resist
Externí odkaz: https://doaj.org/article/cd1cc17edb3f4e4eb7188eb4d10e7a23
Zobrazit plný text záznamu
5
Akademický článek
Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome
Autor: Rui-Lin Ma, Yan Deng, Yan-Fang Wang, Shi-Yang Zhu, Xue-Song Ding, Ai-Jun Sun, Yan-Jie Yin, Xiu-Yuan Hao
Publikováno v: Chinese Medical Journal, Vol 134, Iss 23, Pp 2882-2889 (2021)
Abstract. Background:. Obesity and insulin resistance (IR) are common features of polycystic ovary syndrome (PCOS). Metformin (MET) increases insulin sensitivity, but it is associated with unsatisfactory weight loss. The glucagon-like peptide-1 recep
Externí odkaz: https://doaj.org/article/6a810a6cabaa4673bcc275ea92467c1a
Zobrazit plný text záznamu
6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Preventive therapeutic options for postoperative recurrence of ovarian endometrioma: gonadotropin-releasing hormone agonist with or without levonorgestrel intrauterine system insertion
Autor: Jinhua Leng, Shi-Yang Zhu, Zhiyue Gu, Xiao-yan Li, Yi Dai, Jing Zhang, Shuangzheng Jia, Yu-Shi Wu, Jinghua Shi
Publikováno v: Archives of Gynecology and Obstetrics. 303:533-539
Here, we compared endometrioma recurrence rates in patients who have undergone a laparoscopic cystectomy and treated with a gonadotropin-releasing hormone agonist (GnRHa) alone or a GnRHa combined with a levonogestrel intrauterine system (LND-IUS). W
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e1246f861c63279344bff30d664c0834
https://doi.org/10.1007/s00404-020-05843-5
Zobrazit plný text záznamu
10
Effect of Menopausal Hormone Therapy on Bone Mineral Density in Chinese Women: A 2-Year, Prospective, Open-Label, Randomized-Controlled Trial
Autor: Hong-Ling Zuo, Lihong Gao, Xiao Ma, Ai-Jun Sun, Wei Xue, Yan Deng, Yan-Fang Wang, Shi-Yang Zhu, Hong Xin
Publikováno v: Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
Background This study was designed to explore the effect of menopausal hormone therapy (MHT) on bone mineral density (BMD) in Chinese women. Material/Methods This was a prospective, open-label, randomized-controlled clinical trial. We randomly assign
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7851c98b98191a81027e8994f673471a
http://europepmc.org/articles/PMC6362761
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje